A Danshensu-Tetramethylpyrazine Conjugate DT-010 Overcomes Multidrug Resistance in Human Breast Cancer

Background: We previously demonstrated that a Danshensu-Tetramethylpyrazine conjugate DT-010 enhanced anticancer effect of doxorubicin (Dox) in Dox-sensitive human breast cancer cells, and protected against Dox-induced cardiotoxicity. This work was designed to see whether DT-010 overcomes Dox resist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Zhou, Xinhua, Wang, Anqi, Wang, Liang, Yin, Jianhua, Wang, Li, Di, Lijun, Hoi, Maggie Pui-Man, Shan, Luchen, Wu, Xu, Wang, Yuqiang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606714/
https://ncbi.nlm.nih.gov/pubmed/31293428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00722
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados